Detalles de la búsqueda
1.
Hospital disaster preparedness in sub-Saharan Africa: a systematic review of English literature.
BMC Emerg Med
; 23(1): 71, 2023 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365529
2.
Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women.
J Infect Dis
; 218(8): 1210-1218, 2018 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29800309
3.
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
J Infect Dis
; 215(1): 95-104, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077588
4.
Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya.
PLOS Glob Public Health
; 3(4): e0001741, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043440
5.
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Afr J Lab Med
; 10(1): 1056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833946
6.
Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.
J Clin Invest
; 129(2): 875-886, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30511963
7.
αEß7, α4ß7 and α4ß1 integrin contributions to T cell distribution in blood, cervix and rectal tissues: Potential implications for HIV transmission.
PLoS One
; 13(2): e0192482, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420608
8.
Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
BMJ Open
; 7(9): e017391, 2017 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28939581
9.
Assessment of Anti-HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different Populations.
J Acquir Immune Defic Syndr
; 73(2): 130-7, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27243901
10.
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
Mol Ther Methods Clin Dev
; 3: 16061, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27617268
11.
Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya.
PLoS One
; 9(10): e110228, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25360819
12.
Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods.
AIDS Res Hum Retroviruses
; 27(10): 1067-72, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21406032
13.
Reasons for ineligibility in phase 1 and 2A HIV vaccine clinical trials at Kenya AIDS vaccine initiative (KAVI), Kenya.
PLoS One
; 6(1): e14580, 2011 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21283743
14.
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa.
PLoS One
; 5(9): e12873, 2010 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20877623
15.
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
Clin Vaccine Immunol
; 16(2): 147-55, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19091991
16.
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.
PLoS One
; 4(2): e4401, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19197365
17.
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
PLoS One
; 3(4): e2043, 2008 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-18446196
18.
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.
Vaccine
; 25(11): 2120-7, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17250931
Resultados
1 -
18
de 18
1
Próxima >
>>